F
47
3
MU
28
2
SYY
58
2
MSFT
57
2
T
60
-3
TGNA
48
5
WU
14
2
BF.B
50
-3
VLO
42
2
ABBV
53
-4
HBAN
45
-2
AZO
45
-3
THC
58
-4
NAVI
57
2
KIM
51
-3
AVGO
40
-24
BWA
44
3
HSIC
53
2
AEP
62
-4
CB
58
-2
F
47
3
MU
28
2
SYY
58
2
MSFT
57
2
T
60
-3
TGNA
48
5
WU
14
2
BF.B
50
-3
VLO
42
2
ABBV
53
-4
HBAN
45
-2
AZO
45
-3
THC
58
-4
NAVI
57
2
KIM
51
-3
AVGO
40
-24
BWA
44
3
HSIC
53
2
AEP
62
-4
CB
58
-2
Financhill
Back

Genprex Vs. Denali Therapeutics Industry Stock Comparison

Sell
2

GNPX
Genprex

Last Price:
0.36
Seasonality Move:
-43.52%
Buy
56

DNLI
Denali Therapeutics

Last Price:
30.74
Seasonality Move:
17.79%
Sell
2
Genprex (GNPX) is a Sell

Is Genprex a Buy, Sell or Hold?

  • The current Genprex [GNPX] share price is $0.34. The Score for GNPX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • GNPX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
56
Denali Therapeutics (DNLI) is a Buy

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GNPX Stock Price Chart

What is Genprex's stock price today?

  • The Genprex share price today is $0.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNPX is experiencing slight selling pressure.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $30.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.

GNPX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 12.83 Sell
Chaikin Money Flow: -291040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.73) Sell
Bollinger Bands (100): (1 - 2.5) Sell

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 77.92 Buy
Chaikin Money Flow: 34344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.24 - 27.72) Buy
Bollinger Bands (100): (18.96 - 25.08) Buy

GNPX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.43 Sell
20-day SMA: 0.57 Sell
50-day SMA: 1.18 Sell
200-day SMA: 3.88 Sell
8-day EMA: 0.44 Sell
20-day EMA: 0.61 Sell
50-day EMA: 1.08 Sell
200-day EMA: 5.9 Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28 Buy
20-day SMA: 26.04 Buy
50-day SMA: 24.18 Buy
200-day SMA: 20.53 Buy
8-day EMA: 28.54 Buy
20-day EMA: 26.57 Buy
50-day EMA: 24.56 Buy
200-day EMA: 22.12 Buy

Genprex Earnings Growth & GNPX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.77 per share, an increase next quarter of $2.25 per share, an increase this year of $18.50 per share, and an increase next year of $3.37 per share.

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.

Genprex Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):